Investigating the Effect of Gallic Acid During Acute and Chronic Exposure to Acetaldehyde in Liver Cells: Targeting Epigenetic Modifications
Journal of Biochemical and Molecular Toxicology · 2026-12 · 40 (12)
DOI: 10.1002/jbt.71180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 22.11.2026. Verfasst von Krithika Narayanan und 7 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acetaldehyde (AcH), a toxic byproduct of ethanol metabolism, causes severe liver damage by binding to proteins and DNA and disrupting their functions. Despite extensive research, effective therapies for AcH‐induced toxicity remain limited. This study investigated the protective role of gallic acid (GA), a natural polyphenol, against AcH‐induced epigenetic and cellular alterations in WRL 68 cells following acute (24 h) and chronic (14 days) exposure. During acute exposure to AcH, the ability of GA to protect cells from AcH‐induced cytotoxicity, DNA damage, and apoptosis was assessed using the MTT assay, DNA fragmentation, AO/EtBr dual staining assays, antioxidant analyses, and expression profiling of miRNAs and histone‐modifying enzymes. GA (30 μM) significantly improved cell viability and reduced AcH‐induced cytotoxicity, DNA damage, and apoptosis. It restored redox balance by enhancing SOD, catalase, and GSH levels and decreasing MDA levels. GA normalized dysregulated miRNAs—upregulated (hsa‐miR‐21‐3p, 335‐5p, 17‐5p) and downregulated (hsa‐miR‐199a‐5p, 129‐5p, 26b‐5p, let‐7a‐5p)—and modulated histone‐modifying proteins by increasing HDAC4, HDAC6, G9a, and EZH2 expression while decreasing LSD1 and CBP levels. Under chronic exposure, GA suppressed AcH‐induced epithelial–mesenchymal transition (EMT), indicating its role in mitigating fibrotic progression. Overall, this study highlights that AcH alters epigenetic regulation in WRL 68 cells through miRNA deregulation, histone modifications, and EMT induction, whereas GA effectively reverses these changes. These findings suggest that GA has therapeutic potential for protecting liver cells from AcH‐induced oxidative stress, genotoxicity, and epigenetic alterations.
Zitieren
APA
Narayanan, K., Armstrong, R. N., Natesan, M., Ashok, L., Sakthivel, A., Nagarajan, D., Goud, P., & Thiruvengadam, M. (2026). Investigating the Effect of Gallic Acid During Acute and Chronic Exposure to Acetaldehyde in Liver Cells: Targeting Epigenetic Modifications. Journal of Biochemical and Molecular Toxicology, 40(12). https://doi.org/10.1002/jbt.71180
Vancouver
Narayanan K, Armstrong RN, Natesan M, Ashok L, Sakthivel A, Nagarajan D, et al. Investigating the Effect of Gallic Acid During Acute and Chronic Exposure to Acetaldehyde in Liver Cells: Targeting Epigenetic Modifications. Journal of Biochemical and Molecular Toxicology. 2026;40(12). doi:10.1002/jbt.71180
BibTeX
@article{Narayanan2026,
author = {Narayanan, Krithika and Armstrong, Rubin Nishanth and Natesan, Maheshvare and Ashok, Lathika and Sakthivel, Abinaya and Nagarajan, Devipriya and Goud, Pavan and Thiruvengadam, Muthu},
title = {Investigating the Effect of Gallic Acid During Acute and Chronic Exposure to Acetaldehyde in Liver Cells: Targeting Epigenetic Modifications},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
volume = {40},
number = {12},
doi = {10.1002/jbt.71180}
}
EUVIMED